Cargando…

One-year follow-up of patients treated with single antiplatelet therapy directly after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome

[Figure: see text]

Detalles Bibliográficos
Autores principales:	van der Sangen, Niels M R, Claessen, Bimmer E P M, Küçük, I Tarik, den Hartog, Alexander W, Kikkert, Wouter J, Appelman, Yolande, Henriques, José P S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482140/ https://www.ncbi.nlm.nih.gov/pubmed/37680589 http://dx.doi.org/10.1093/ehjopen/oead075

Ejemplares similares

Long-term ischaemic and bleeding outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction in the elderly
por: Claessen, Bimmer E.P.M., et al.
Publicado: (2015)

Residual Inflammatory Risk After Percutaneous Coronary Intervention: Underappreciated But Modifiable
por: van Veelen, Anna, et al.
Publicado: (2022)

Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023)

Detection of Vulnerable Coronary Plaques Using Invasive and Non-Invasive Imaging Modalities
por: van Veelen, Anna, et al.
Publicado: (2022)

Cyclic ST-segment elevation after primary percutaneous coronary intervention
por: Jansen, W. P. J.
Publicado: (2020)

Cangrelor Use in Routine Practice: A Two-Center Experience
por: van der Sangen, Niels M. R., et al.
Publicado: (2021)

Patient-tailored antithrombotic therapy following percutaneous coronary intervention
por: van der Sangen, Niels M R, et al.
Publicado: (2021)

Effectiveness of dual antiplatelet de-escalation therapy on the prognosis of patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhao, Zhigang, et al.
Publicado: (2023)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Therapeutic application of contrast ultrasound in ST elevation myocardial infarction: Role in coronary thrombosis and microvascular obstruction
por: Slikkerveer, Jeroen, et al.
Publicado: (2017)

Persistence with dual antiplatelet therapy after percutaneous coronary intervention for ST-segment elevation acute coronary syndrome: a population-based cohort study in Catalonia (Spain)
por: Ribera, Aida, et al.
Publicado: (2019)

Optimal duration of dual antiplatelet therapy for coronary artery disease
por: Kikkert, W. J., et al.
Publicado: (2018)

Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparin
por: Kikkert, Wouter J., et al.
Publicado: (2015)

ST Segment Elevation with Normal Coronaries
por: Sethi, Pooja, et al.
Publicado: (2016)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Antiplatelet Therapy and Percutaneous Coronary Interventions
por: Davanzo, Rene Hameau, et al.
Publicado: (2021)

Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
por: Gąsior, Paweł, et al.
Publicado: (2013)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020)

Double stent loss during multivessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome
por: Hawranek, Michał, et al.
Publicado: (2014)

Prognostic value of the C-reactive protein to albumin ratio in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: SÖĞÜT, Özgür, et al.
Publicado: (2021)

Population Density Analysis of Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction in Japan
por: Yamaji, Kyohei, et al.
Publicado: (2020)

Intensity of antiplatelet therapy and percutaneous coronary intervention
por: Aronow, Wilbert S
Publicado: (2009)

External validation of the GRACE risk score and the risk–treatment paradox in patients with acute coronary syndrome
por: van der Sangen, Niels M R, et al.
Publicado: (2022)

Staged versus One-Time Percutaneous Coronary Intervention Strategy for Multivessel Non-ST Segment Elevation Acute Coronary Syndrome
por: Kim, Yun Gi, et al.
Publicado: (2016)

Effect of metformin on outcome in patients undergoing primary percutaneous coronary intervention for st-segment elevation myocardial infarction
por: Posma, RA, et al.
Publicado: (2015)

Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction
por: van der Schaaf, René J, et al.
Publicado: (2010)

Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST‐Segment–Elevation Myocardial Infarction (GUARD)
por: Sezer, Murat, et al.
Publicado: (2022)

Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary Interventions
por: Summaria, Francesco, et al.
Publicado: (2015)

Stent Thrombosis after Rescue Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction
por: Thani, Khalid Bin, et al.
Publicado: (2015)

Smoker's Paradox in Patients With ST‐Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Tanush, et al.
Publicado: (2016)

Treatment Effect of Percutaneous Coronary Intervention in Men Versus Women With ST‐Segment–Elevation Myocardial Infarction
por: Sulaiman, Samian, et al.
Publicado: (2021)

Fibrinolysis vs. primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2021)

Early percutaneous coronary intervention and in-hospital mortality in non st elevation coronary syndromes
por: Cebrián Domenech, J, et al.
Publicado: (2015)

Role of ST‐Segment Resolution Alone and in Combination With TIMI Flow After Primary Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction
por: Wu, Chao, et al.
Publicado: (2023)

Recovery of right ventricular function and strain in patients with ST-segment elevation myocardial infarction and concurrent chronic total occlusion
por: van Veelen, Anna, et al.
Publicado: (2021)

Clinical Significance of On-Treatment Triglyceride Level in Patients Treated by Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome
por: Yun, Kyeong Ho, et al.
Publicado: (2009)

Prognostic implication of serum glycated albumin for patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention
por: Liu, Chi, et al.
Publicado: (2022)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Income and antiplatelet adherence following percutaneous coronary intervention
por: LaRosa, Anna R., et al.
Publicado: (2022)

When is the Best Time for the Second Antiplatelet Agent in Non-St Elevation Acute Coronary Syndrome?
por: Silva, Pedro Gabriel Melo de Barros e, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kghao2jqb0a9d3fiskugriodk0